- Home
- LFMD vs AQST Comparison
LFMD vs AQST Comparison
Compare LFMD & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFMD
- AQST
- Stock Information
- Founded
- LFMD 1994
- AQST 2004
- Country
- LFMD United States
- AQST United States
- Employees
- LFMD N/A
- AQST N/A
- Industry
- LFMD Medical/Nursing Services
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- LFMD Health Care
- AQST Health Care
- Exchange
- LFMD Nasdaq
- AQST Nasdaq
- Market Cap
- LFMD 306.7M
- AQST 274.4M
- IPO Year
- LFMD N/A
- AQST 2018
- Fundamental
- Price
- LFMD $5.44
- AQST $2.94
- Analyst Decision
- LFMD Strong Buy
- AQST Strong Buy
- Analyst Count
- LFMD 7
- AQST 7
- Target Price
- LFMD $11.57
- AQST $10.57
- AVG Volume (30 Days)
- LFMD 1.6M
- AQST 1.4M
- Earning Date
- LFMD 03-10-2025
- AQST 03-05-2025
- Dividend Yield
- LFMD N/A
- AQST N/A
- EPS Growth
- LFMD N/A
- AQST N/A
- EPS
- LFMD N/A
- AQST N/A
- Revenue
- LFMD $212,453,838.00
- AQST $57,561,000.00
- Revenue This Year
- LFMD $23.50
- AQST N/A
- Revenue Next Year
- LFMD $17.20
- AQST $39.51
- P/E Ratio
- LFMD N/A
- AQST N/A
- Revenue Growth
- LFMD 39.27
- AQST 13.79
- 52 Week Low
- LFMD $3.99
- AQST $2.24
- 52 Week High
- LFMD $12.88
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- LFMD 46.61
- AQST 47.23
- Support Level
- LFMD $5.47
- AQST $3.05
- Resistance Level
- LFMD $6.15
- AQST $3.24
- Average True Range (ATR)
- LFMD 0.41
- AQST 0.20
- MACD
- LFMD 0.01
- AQST 0.02
- Stochastic Oscillator
- LFMD 22.06
- AQST 36.18
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.